News

Patient Reported Quality of Life at Diagnosis Correlates to Survival Rates for Aggressive Lymphomas

In non, eu aliquam mus eu aptent mi justo. Nam nonummy, eget tempor facilisis diam. Et in ut, est dignissim, wisi pellentesque amet est dignissim, in mi vestibulum montes eu nullam.

Researchers Establish 12 Months Event-Free Survival as Clinical Endpoint for Follicular Lymphoma

Though much of the lymphoma research presented at the Annual Meeting of the American Society of Hematology (ASH) in December 2014 focused on the growing number of novel therapies for this disease.

Gender and Body Mass Index May Effect Treatment Outcomes in Older DLBCL Patients

Cras faucibus vel sed maecenas consectetuer, iaculis montes leo, scelerisque lorem sollicitudin, quis quam condimentum nisl.

Studies Assess PET Scans as Tool for Guiding Therapy in Lymphoma

Though much of the lymphoma research presented at the Annual Meeting of the American Society of Hematology (ASH) in December 2014 focused on the growing number of novel therapies for this disease, a subset of presentations focused on the impact…

Patients with HIV-Related Lymphoma Can Successfully Undergo Autologous Stem-Cell Transplant

Placerat diam luctus orci nec diam mauris, placerat sodales hac nunc risus.

Double Hit Lymphoma Studies Hot Topic at 2014 ASH Annual Meeting

Double hit lymphoma (DHL) describes patients whose lymphoma tumors exhibit mutations on two significant genes, where most lymphoma patients have a mutation on only one. Currently found primarily in diffuse large B-cell lymphoma (DLBCL), DHL patients often respond poorly to…

ASH 2014 Features Promising New Treatments for Hodgkin Lymphoma

Among the many exciting clinical trials results presented at the Annual Meeting of the American Society of Hematology (ASH) in December 2014, were three significant studies for Hodgkin Lymphoma (HL) patients. The studies, which included early stage studies of two…